These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23756255)

  • 61. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
    Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P
    Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Roles of human epidermal growth factor receptor family in pulmonary lymphangioleiomyomatosis.
    Kobayashi K; Miki Y; Saito R; Adachi K; Seyama K; Okada Y; Sasano H
    Hum Pathol; 2018 Nov; 81():121-130. PubMed ID: 30030119
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overexpression of HER2/HER3 and clinical feature of ovarian cancer.
    Chung YW; Kim S; Hong JH; Lee JK; Lee NW; Lee YS; Song JY
    J Gynecol Oncol; 2019 Sep; 30(5):e75. PubMed ID: 31328457
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The involvement of EGFR, HER2 and HER3 in the basal cell carcinomas aggressiveness.
    Florescu DE; Stepan AE; Mărgăritescu C; Ciurea RN; Stepan MD; Simionescu CE
    Rom J Morphol Embryol; 2018; 59(2):479-484. PubMed ID: 30173251
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The immunoexpression of EGFR, HER2 and HER3 in malignant serous ovarian tumors.
    Cîrstea AE; Stepan AE; Mărgăritescu C; Zăvoi RE; Olimid DA; Simionescu CE
    Rom J Morphol Embryol; 2017; 58(4):1269-1273. PubMed ID: 29556616
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.
    Sun D; Li X; Ma M; Liu J; Xu Y; Ye L; Hou H; Wang C; Li X; Jiang Y
    Jpn J Clin Oncol; 2015 May; 45(5):464-73. PubMed ID: 25646356
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases.
    Ponce S; Bruna J; Juan O; López R; Navarro A; Ortega AL; Puente J; Verger E; Bartolomé A; Nadal E
    Crit Rev Oncol Hematol; 2019 Jun; 138():190-206. PubMed ID: 31092376
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients.
    Ananiev J; Aleksandrova E; Skerleva D; Gulubova M; Chokoeva A; Lotti T; Wollina U; Tchernev G; Kontić M; Stojšić J
    Wien Med Wochenschr; 2015 Aug; 165(15-16):315-21. PubMed ID: 26208475
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HER3 as a Therapeutic Target in Cancer.
    Karachaliou N; Lazzari C; Verlicchi A; Sosa AE; Rosell R
    BioDrugs; 2017 Feb; 31(1):63-73. PubMed ID: 28000159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predicting brain metastases for non-small cell lung cancer based on magnetic resonance imaging.
    Yin G; Li C; Chen H; Luo Y; Orlandini LC; Wang P; Lang J
    Clin Exp Metastasis; 2017 Feb; 34(2):115-124. PubMed ID: 28101700
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1.
    Kumagai T; Tomita Y; Nakatsuka SI; Kimura M; Kunimasa K; Inoue T; Tamiya M; Nishino K; Susaki Y; Kusu T; Tokunaga T; Okami J; Higashiyama M; Imamura F
    Thorac Cancer; 2018 Apr; 9(4):466-471. PubMed ID: 29473311
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours.
    Srirajaskanthan R; Shah T; Watkins J; Marelli L; Khan K; Caplin ME
    Oncol Rep; 2010 Apr; 23(4):909-15. PubMed ID: 20204273
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.
    Ilhan-Mutlu A; Siehs C; Berghoff AS; Ricken G; Widhalm G; Wagner L; Preusser M
    Tumour Biol; 2016 Jan; 37(1):1173-82. PubMed ID: 26277786
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
    Hirsch FR; Scagliotti GV; Langer CJ; Varella-Garcia M; Franklin WA
    Lung Cancer; 2003 Aug; 41 Suppl 1():S29-42. PubMed ID: 12867060
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer.
    Lai WW; Chen FF; Wu MH; Chow NH; Su WC; Ma MC; Su PF; Chen H; Lin MY; Tseng YL
    Ann Thorac Surg; 2001 Dec; 72(6):1868-76. PubMed ID: 11789762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The HER family as therapeutic targets in colorectal cancer.
    Ye P; Wang Y; Li R; Chen W; Wan L; Cai P
    Crit Rev Oncol Hematol; 2022 Jun; 174():103681. PubMed ID: 35462030
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.
    Bosch-Barrera J; Sais E; Cañete N; Marruecos J; Cuyàs E; Izquierdo A; Porta R; Haro M; Brunet J; Pedraza S; Menendez JA
    Oncotarget; 2016 May; 7(22):32006-14. PubMed ID: 26959886
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
    Saad AG; Yeap BY; Thunnissen FB; Pinkus GS; Pinkus JL; Loda M; Sugarbaker DJ; Johnson BE; Chirieac LR
    Cancer; 2008 Oct; 113(8):2129-38. PubMed ID: 18720359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunohistochemical expression of ErbB/HER family proteins in patients with vulvar cancer.
    Baiocchi G; de Freitas RR; Bovolim G; Badiglian-Filho L; da Costa AABA; De Brot L
    Int J Gynaecol Obstet; 2022 Apr; 157(1):102-109. PubMed ID: 34270807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of the epidermal growth factor receptor protein expression between primary non-small cell lung cancer and paired lymph node metastases: implications for targeted nuclide radiotherapy.
    Rao C; Hu Q; Ma J; Li J; Zhang C; Shen L; Wei Q
    J Exp Clin Cancer Res; 2010 Jan; 29(1):7. PubMed ID: 20096104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.